Patents by Inventor MARC FERRANTE

MARC FERRANTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREDICTING A TREATMENT RESPONSE IN INFLAMMATORY BOWEL DISEASE
    Publication number: 20220364171
    Abstract: In general the present invention concerns a method for predicting the therapeutic outcome of a treatment of in inflammatory bowel disease for anti-TNF agents, anti-?4?7-integrin agents and/or anti-IL-12/23 agents. The method defines which the agents are likely to provide the best healing effect for a particular patients affected by an inflammatory bowel disease. In particular the method predicts the therapeutic outcome of a treatment of anti-TNF agents in inflammatory bowel disease.
    Type: Application
    Filed: November 25, 2019
    Publication date: November 17, 2022
    Inventors: Séverine VERMEIRE, Bram VERSTOCKT, Marc FERRANTE
  • Methods for predicting post-operative recurrence of Crohn's disease
    Patent number: 10697961
    Abstract: The present invention provides methods for predicting post-operative recurrence of Crohn's disease (CD) in a subject. With the present invention it is possible to predict whether a patient undergoing surgical treatment of CD is at risk of developing histological, radiographic, endoscopic, and/or clinical recurrence of the disease.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: June 30, 2020
    Assignees: Prometheus Biosciences, Inc., Katholieke Universiteit Leuven
    Inventors: Steven Lockton, Marc Ferrante, Severine Vermiere, Sharat Singh
  • METHODS FOR PREDICTING POST-OPERATIVE RECURRENCE OF CROHN'S DISEASE
    Publication number: 20160334401
    Abstract: The present invention provides methods for predicting post-operative recurrence of Crohn's disease (CD) in a subject. With the present invention it is possible to predict whether a patient undergoing surgical treatment of CD is at risk of developing histological, radiographic, endoscopic, and/or clinical recurrence of the disease.
    Type: Application
    Filed: May 20, 2016
    Publication date: November 17, 2016
    Applicants: NESTEC S.A., UNIVERSITY HOSPITALS LEUVEN
    Inventors: STEVEN LOCKTON, MARC FERRANTE, SEVERINE VERMIERE, SHARAT SINGH